what do u expect from this counter? what s the catalyst for it to move uptrend? bear in mind the manufacturing biz no longer profitable. as for the building materials biz, it s a new venture with additional shares issuance which by right would dilute the share price as now. the profit margin of the building materials is still low for now.

just put this aside and hope to receive dividends in 2025 and 2026. every dog has its days and possible this counter may back to 0.25-0.3. I don't expect it to have any rally or strong recovery in the near term as there is nothing to support higher valuation for now.

I don't think you have to wait for 3 years to decide. The 100% tariffs on China gloves starting Jan'25 means Malaysia glove producers with exports to US (the top 4) will potentially see increased demand to US next year. Esceram's glove formers should see increased demand in tandem with higher production from the glove manufacturers. FY25 performance should be able to see that. Can decide what to do within the next two qtrs performance.

China gloves tariffs theme kicks in starting Jan'25. Glove manufacturers with US exports are the potential beneficiaries; on-going higher production utilization which means more glove formers needed particularly the stringent requirements of medical gloves. Glove formers/manufacturing is high margin segment for Esceram.

esceramix made a fortune during covid which enable it to have enough fund to acquire the new business. as for the gloves former manufacturing, there s not much progress or investment into it for the past few years. I don't see any expansion on that biz in near term as they have closed some manufacturing lines and impaired them earlier this year.

the top 4 glove manufacturers started to increase productions based on their recent reports. It makes sense as glove production batches manufactured back in 2019/2020 are either expired or expiring; 3 years for latex gloves and 5 years for nitrile gloves. and current market price for esceram is at the bottom while the industry cycle is moving up :)

Had a quick look at the 2018 income statement / p&l, Eddy. The low net profit seems to be due to inventories written off and impairment of receivables; totalling 1.7M. Didnt notice any significant write-off and impairment in FY2019. Demand for glove formers spikes in tandem with the demand for gloves.

Hope you are also trading the top 4 glove manufacturers with US export, Eddy :) we have been exchanging opinions here on the shelf-life of latex and nitrile gloves and the US tariffs. The optimism started to kick in when Trump won the election - anticipation of heightened China tariffs / trade wars. Keep a trailing stop if you have any of the top 4 glove stocks on hands - keep an eye on the tones post Trump inauguration.